Health & Biotech
Check out the latest COVID-19 and Coronavirus news, insights and unique analysis brought to you by Stockhead’s team of business journalists and industry experts.
News
Unemployment in Australia dropped further in December; but ‘challenges remain’ for the economy
News
ASX construction stocks are on the rebound thanks to a $50bn-powered boom
Food & Agriculture
Cannabis stock Australian Primary Hemp wins Woolworths supply deal
Health & Biotech
Skin Elements ready to launch ‘game changing’ anti-COVID disinfectant range
News
These ASX-listed lenders are benefiting from rising lending volumes
Health & Biotech
Neuroscientific is researching a potential cure for post-COVID lung damage
Tech
Security Matters’ blockchain platform could aid vaccine rollout
News
Here are the ASX stocks Wilson Asset Management is looking at right now
News
The good times are rolling on for Bell Financial and Australian Ethical
News
These 6 investor trends will define 2021… and beyond
News
As workers get dragged back to offices, this broker tips these ASX REITs to benefit
News
Airbnb breaks into top 10 US stocks for Australian investors
Experts
Money Talks: Here are Barclay Pearce’s top 2021 ASX picks
Guides
2020 ASX Small Cap Winners List: 101 stocks gained over 300 per cent
News
Global equity markets have ignored COVID-19 since March crash, study shows
News
Here’s what Australia’s daigou trade will look like in 2021, once international students return
News
These are the stocks you traded most in 2020
News
Weekly ASX small cap wrap: Which ASX stock is hosting a Christmas sleepover?
Health & Biotech
Mesoblast shares smashed after COVID study setback
Tech
Australia’s neobanks’ future is clouded after Xinja’s fall, but here’s how entrants could succeed
Health & Biotech
CSL dips after abandoning University of Queensland COVID vaccine trial
News
COVID-19 has shifted people’s money habits; here are the ASX financial stocks that could benefit
Health & Biotech
Telehealth in 2021: What will change and will a COVID-19 vaccine stop the sector’s growth?
Private-i
Aegros developing COVID-19 hyperimmune solution for front-line healthcare workers
Tech
Tonight, the Airbnb IPO could value the guest hosting juggernaut at $56.5bn
News
The 2021 outlook for shares: State Street predicts growth and quality assets to shine
News
The ‘basket of stocks’ approach is helping Australian investors hunt market thematics
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Who else on the ASX joins Mesoblast in the fight against ARDS and where are they at?
Health & Biotech
Mesoblast COVID-19 therapy granted fast-track designation
News
Five niche ASX retail stocks that are winners in 2020 in defiance of COVID-19
Health & Biotech
Mesoblast in potential $1.7bn partnership with Novartis to develop remestemcel-L
News
ASX back in rally mode after outage; Universal Store goes live and gains 20pc
News
The border closures to South Australia: Have they dented the tourism sector’s confidence again?
Experts
MoneyTalks: A few more hot picks out of COVID from Canary Capital
News
Weekly ASX Small Cap Wrap: Who’s finally found their greatest gift this week?
News
ASX Small Cap Lunch Wrap: Reality check – there’s more ‘COVID vaccine waiting’ to do
News
ASX Small Cap Lunch Wrap: Global stocks are now overweight and that’s a good thing
Health & Biotech
The ASX biotech companies that lost puff on Pfizer vaccine news
News
Closing Bell: Today’s biggest small cap movers on the ASX
Experts
Buy everything? Experts warn Pfizer COVID vaccine rally ‘premature’
News
These ASX stocks are surging (and falling) on the Pfizer vaccine news
News
10 at 10: These ASX stocks are the focal point this morning – thanks to the Pfizer vaccine news
Health & Biotech
Global study will test Dimerix drug compound DMX-200 as COVID-19 treatment
News
Childcare stock Evolve Education climbs after earnings guidance; plans to hit acquisition trail again
News
Trading Places: Alex Waislitz’s Thorney Opportunities chipped in to these ASX stocks
Experts
So, the RBA turned to quantitative easing – what does it mean for ASX small caps?
Load More
